Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease

ClinicalTrials.gov ID: NCT01689246

Public ClinicalTrials.gov record NCT01689246. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 11:55 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease

Study identification

NCT ID
NCT01689246
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
TauRx Therapeutics Ltd
Industry
Enrollment
891 participants

Conditions and interventions

Interventions

  • TRx0237 150 mg/day Drug
  • TRx0237 250 mg/day Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
Up to 89 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2012
Primary completion
Oct 31, 2015
Completion
Oct 31, 2015
Last update posted
Mar 13, 2018

2013 – 2015

United States locations

U.S. sites
26
U.S. states
13
U.S. cities
26
Facility City State ZIP Site status
Xenoscience, Inc/ 21st Century Neurology Phoenix Arizona 85004
Feldman, Robert MD Laguna Hills California 92653
University of Southern California Los Angeles California 90033
Shankle Clinic and Hoag Memorial Hospital Presbyterian Newport Beach California 92658
Pacific Research Network San Diego California 92103
San Francisco Clinical Research Center San Francisco California 94118
Yale University School of Medicine New Haven Connecticut 06510
JEM Research Atlantis Florida 33462
Brain Matters Research Delray Beach Florida 33445
CNS Healthcare, Inc Jacksonville Florida 32256
Compass Research, LLC-North Clinic Leesburg Florida 34748
Miami Research Associates Miami Florida 33143
Compass Research, LLC Orlando Florida 32806
iResearch Atlanta Decatur Georgia 30030
Alexian Brothers Neurosciences Institute Elk Grove Illinois 60007
ActivMed Practices & Research Methuen Massachusetts 01844
Olive Branch Family Medical Olive Branch Mississippi 38654
Memory Enhancement Centers of America, Inc Eatontown New Jersey 07724
CRI Worldwide Marlton New Jersey 08053
The Cognitive Research Center of New Jersey Springfield New Jersey 07801
Advanced Memory Research Institute of NJ PC Toms River New Jersey 08757
Neurological Associates of Albany, P. C. Albany New York 12208
SPRI Brooklyn New York 11235
Neurobehavioral Clinical Research Canton Ohio 44718
The Clinical Trial Center, LLC Jenkintown Pennsylvania 19046
FutureSearch Trials of Neurology Austin Texas 78731

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 95 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01689246, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 13, 2018 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01689246 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →